Ep. 12: How IBD Called The Correction – And Where It May Go




Investing with IBD show

Summary: This week, IBD Chief Content Officer Chris Gessel joined the podcast to discuss "vertical violations," which can be used to spot prolonged sell-offs. We also look at three stocks that are bucking the downtrend: Repligen, Anaplan and Insulet. Plus, Randy Watts of William O'Neil + Co. returns for a sponsored interview with Doug Peebles, Chief Investment Officer of Fixed Income at AllianceBernstein, about fixed income strategies. For the video version, show notes and charts, go to investors.com/podcast.